当前位置:首页 - 行情中心 - 回盛生物(300871) - 财务分析 - 现金流量表

回盛生物

(300871)

  

流通市值:33.46亿  总市值:33.46亿
流通股本:2.02亿   总股本:2.02亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,098,115,568.96703,787,770.86345,560,420.551,308,078,441.82
  收到的税费返还1,776,779.581,152,199.51982,083.4210,765,600.17
  收到其他与经营活动有关的现金74,876,017.8160,086,873.1223,831,109.0783,790,485.3
  经营活动现金流入小计1,174,768,366.35765,026,843.49370,373,613.041,402,634,527.29
  购买商品、接受劳务支付的现金660,192,727.67406,279,308.57195,358,121.66777,275,720.96
  支付给职工以及为职工支付的现金135,263,982.895,594,928.8554,610,564.16149,028,972.3
  支付的各项税费86,638,421.6363,066,507.3626,927,525.684,533,881.3
  支付其他与经营活动有关的现金93,228,703.0471,815,539.2540,857,102.92153,347,555.73
  经营活动现金流出小计975,323,835.14636,756,284.03317,753,314.341,164,186,130.29
  经营活动产生的现金流量净额199,444,531.21128,270,559.4652,620,298.7238,448,397
二、投资活动产生的现金流量:
  收回投资收到的现金428,630,928.63348,630,928.63132,961,200649,606,605.64
  取得投资收益收到的现金2,508,476.722,038,043.061,401,730.487,100,045.12
  处置固定资产、无形资产和其他长期资产收回的现金净额83,687,346.6417,609,872.46-397,577.82
  处置子公司及其他营业单位收到的现金净额-71,257.46-71,257.46-71,257.46-
  投资活动现金流入小计514,755,494.53368,207,586.69134,291,673.02657,104,228.58
  购建固定资产、无形资产和其他长期资产支付的现金393,361,981234,633,482.5970,847,142.9496,919,488.2
  投资支付的现金501,290,349.85417,745,299.85192,519,400615,025,416.26
  投资活动现金流出小计894,652,330.85652,378,782.44263,366,542.94711,944,904.46
  投资活动产生的现金流量净额-379,896,836.32-284,171,195.75-129,074,869.92-54,840,675.88
三、筹资活动产生的现金流量:
  吸收投资收到的现金---375,000
  其中:子公司吸收少数股东投资收到的现金---375,000
  取得借款收到的现金564,159,250424,250,000199,950,000220,000,000
  收到其他与筹资活动有关的现金31,167,14226,839,79612,680,10238,449,132
  筹资活动现金流入小计595,326,392451,089,796212,630,102258,824,132
  偿还债务支付的现金292,500,000210,000,00094,000,000368,075,007.66
  分配股利、利润或偿付利息支付的现金106,089,484.944,098,780.741,459,849.9749,919,954.46
  其中:子公司支付给少数股东的股利、利润724,662.08724,662.08--
  支付其他与筹资活动有关的现金30,201,06329,582,91867,2001,067,928.3
  筹资活动现金流出小计428,790,547.94243,681,698.7495,527,049.97419,062,890.42
  筹资活动产生的现金流量净额166,535,844.06207,408,097.26117,103,052.03-160,238,758.42
四、汇率变动对现金及现金等价物的影响-1,762,594.01-1,073,785.09-881,004.09-1,837,642.35
五、现金及现金等价物净增加额-15,679,055.0650,433,675.8839,767,476.7221,531,320.35
  加:期初现金及现金等价物余额206,123,263.59206,123,263.59206,123,263.59184,591,943.24
  期末现金及现金等价物余额190,444,208.53256,556,939.47245,890,740.31206,123,263.59
补充资料:
  净利润-206,442,070.79-253,488,650.71
  资产减值准备-6,726,375.29-8,949,906.1
  固定资产和投资性房地产折旧-61,164,000.72-116,997,069.72
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-61,164,000.72-116,997,069.72
  无形资产摊销-1,730,732.41-3,368,021.54
  长期待摊费用摊销-177,349.8-952,845.13
  处置固定资产、无形资产和其他长期资产的损失--51,320,110.04--
  固定资产报废损失-9,338.62-614,061.75
  公允价值变动损失--4,481,812.46--1,204,788.1
  财务费用-5,280,339.54-15,972,262.68
  投资损失--605,161.33--8,886,087.59
  递延所得税--985,179.15--4,290,088.64
  其中:递延所得税资产减少--812,490.79-1,883,107.58
    递延所得税负债增加--172,688.36--6,173,196.22
  存货的减少--20,705,345.58--22,942,933.64
  经营性应收项目的减少--97,093,253.28--43,451,396.91
  经营性应付项目的增加-10,156,655.44--83,730,639.73
  其他-11,774,558.69-2,611,513.98
  现金的期末余额-256,556,939.47-206,123,263.59
  减:现金的期初余额-206,123,263.59-184,591,943.24
  现金及现金等价物的净增加额-50,433,675.88-21,531,320.35
公告日期2026-10-232026-08-152026-04-282026-04-17
审计意见(境内)标准无保留意见
TOP↑